NCT02262650View on ClinicalTrials.gov

Relative Bioavailability of Telmisartan and SR26334 After Co-administration Compared to the Bioavailability of Telmisartan and SR26334 After Administration of Telmisartan and Clopidogrel Alone in Healthy Male and Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

May 31, 2004

Conditions
Healthy
Interventions
DRUG

Telmisartan

DRUG

Clopidogrel

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02262650 - Relative Bioavailability of Telmisartan and SR26334 After Co-administration Compared to the Bioavailability of Telmisartan and SR26334 After Administration of Telmisartan and Clopidogrel Alone in Healthy Male and Female Subjects | Biotech Hunter | Biotech Hunter